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Gene-distal enhancers are critical for tissue-specific
gene expression, but their genomic determinants
within a specific lineage at different stages of devel-
opment are unknown. Here we profile chromatin
state maps, transcription factor occupancy, and
gene expression profiles during human erythroid
development at fetal and adult stages. Comparative
analyses of human erythropoiesis identify develop-
mental stage-specific enhancers as primary determi-
nants of stage-specific gene expression programs.
We find that erythroid master regulators GATA1
and TAL1 act cooperatively within active enhancers
but confer little predictive value for stage specificity.
Instead, a set of stage-specific coregulators collabo-
rates with master regulators and contributes to
differential gene expression. We further identify and
validate IRF2, IRF6, and MYB as effectors of an
adult-stage expression program. Thus, the combina-
torial assembly of lineage-specific master regulators
and transcriptional coregulators within develop-
mental stage-specific enhancers determines gene
expression programs and temporal regulation of
transcriptional networks in a mammalian genome.
INTRODUCTION
Erythropoiesis in mammals occurs in three waves consisting of
primitive progenitors in the yolk sac, definitive precursors in
the fetal liver and later in the postnatal bone marrow (McGrath
and Palis, 2008; Orkin and Zon, 2008). Several transcription
factors (TFs), such as GATA1 and TAL1 (or SCL), are essential
for erythroid development and are recognized as the erythroid
‘‘master’’ regulators (Cantor and Orkin, 2002). These lineage-796 Developmental Cell 23, 796–811, October 16, 2012 ª2012 Elsevspecifying master regulators, together with other transcription
factors and cofactors, act within complexes on chromatin,
establish transcriptional networks, and orchestrate differentia-
tion (Kim and Bresnick, 2007). Master regulators of different line-
ages often cross-antagonize each other’s activity during lineage
specification (Graf and Enver, 2009). However, it is less clear how
master regulators control programs at different stages of devel-
opment within the same cell lineage.
A gene regulatory network consists of trans-acting regulators
and cis-acting elements within core promoters and gene-distal
enhancers whose interaction with each other control tissue-
and developmental stage-specific programs (Bulger and Grou-
dine, 2011). Genome-wide studies suggest that enhancers and
promoters exhibit distinct chromatin ‘‘signatures.’’ The charac-
teristic signature for enhancers consists of monomethylation
of histone H3 lysine 4 (H3K4me1), acetylation of histones
(H3K9ac and H3K27ac), and binding of the acetyltransferase
p300 (Heintzman et al., 2007; Koch et al., 2007; Visel et al.,
2009). Studies comparing various lineages indicate that en-
hancers are associated with highly cell-type-specific histone
modifications and strongly correlate to global cell-type-specific
programs (Blow et al., 2010; Creyghton et al., 2010; Ernst
et al., 2011; Ghisletti et al., 2010; Heintzman et al., 2009; Mikkel-
sen et al., 2010; Rada-Iglesias et al., 2011). Hence, it has been
suggested that enhancers are the primary determinants of cell-
type specificity in gene expression. However, the majority of
studies have employed cells from very different lineages and/
or immortalized cell lines. It remains unknown the degree of over-
lap between cells within a specific lineage at different stages of
differentiation or similar cells at different stages of development.
We reasoned that comparative profiling of closely related cell
types corresponding to distinct developmental stages should
delineate regulatory networks directly related to the associated
gene expression programs. Classification of the trans- and cis-
regulatory elements that are either shared or stage specific
should clarify their relative importance and prioritize functional
candidates. We have focused on an ex vivo maturation system
for human fetal and adult erythropoiesis. Primary hematopoieticier Inc.
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Figure 1. Comparative Genomic Analyses
of Human Erythropoiesis
(A) Fetal and adult CD34+ HSPCs were differenti-
ated into ProEs ex vivo. Cells at matched stages of
differentiation were collected for gene expression
profiling and ChIP-seq analyses.
(B) Expression of human embryonic (ε), fetal (g),
and adult (b) globin mRNAs. Results are means ±
SD of at least three independent experiments.
(C) Scatterplots of gene expression profiling
between fetal and adult ProEs (F5 and A5). Dashed
blue lines indicate the 1.5-fold differential expres-
sion cutoff to define the F5-high (increased
expression in F5 relative to A5 ProEs) or A5-high
(increased expression in A5 relative to F5 ProEs)
genes. The numbers of differentially expressed
genes are indicated.
(D) Numbers of differentially expressed genes
conditional on changes in expression levels
between A5 and F5 ProEs.
(E) The genome-wide distribution of the profiled
histone marks and TFs. Total numbers of enriched
regions in distal promoters (blue), proximal pro-
moters (red), exons (green), introns (purple), and
intergenic regions (light blue) are identified
(Experimental Procedures). The graph shows the
fraction of enriched regions for each histone mark
and TF in fetal and adult ProEs, respectively.
See also Figures S1 and S2, and Tables S1 and S2.
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Developmental Stage-Specific Erythroid Enhancersstem/progenitor cells (HSPCs) can be propagated and induced
for erythroid differentiationwith a set of defined cytokines ex vivo.
This system has been widely used in molecular analysis of eryth-
ropoiesis (Migliaccio et al., 2009).
Here, we report the comparative investigation of genome-
wide chromatin statemaps, TF occupancy, and gene expression
profiles from developing red cell precursors at two develop-
mental stages. Distal enhancers, not promoters, are marked
with highly stage-specific histone modifications and DNase I
hypersensitivity, strongly correlate to stage-specific gene ex-
pression changes, and are functionally active in a stage-specific
manner. Master regulators GATA1 and TAL1 act cooperatively
within active enhancers but have little predictive value for
stage-specific enhancer activity. In contrast, a set of stage-
specific cofactors and signaling pathways collaborate with theseDevelopmental Cell 23, 796–811,regulators and account for the stage
specificity. Two such cofactors, the inter-
feron regulatory factors (IRFs) 2 and 6,
are essential for activation of adult ery-
throid programs through cooperation
with master regulators and cohesin-
mediator complexes at distal enhancers.
RESULTS
Ex Vivo Maturation of Primary
Human Fetal and Adult Erythroid
Progenitors
We employed a serum-free two-phase
liquid culture system to expand and differ-
entiate primary fetal or adult-stage humanCD34+HSPCs ex vivo (Sankaran et al., 2008). In this experimental
context, highly enriched populations of stage-matched, differenti-
ating,primaryproerythroblasts (ProEs)weregenerated (Figure1A).
We selected four time points (day 0, CD34+ HSPCs; days 3, 5,
and 7, differentiating ProEs) that represented similar stages of
differentiation (Figure 1A; see Figures S1A, and S1B available
online). Adult CD34+ HSPC-derived ProEs expressed predomi-
nantly adult hemoglobin (b-globin). Conversely, fetal ProEs ex-
pressed largely fetal hemoglobin (g-globin) (Figure 1B), indicating
that the ex vivo system faithfully recapitulates stage specificity.
Comparative Profiling of Gene Expression, Chromatin
Signatures, and Transcription Factor Occupancy
We determined the mRNA expression profiles in fetal and
adult HSPCs and differentiating ProEs by Affymetrix microarrayOctober 16, 2012 ª2012 Elsevier Inc. 797
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Developmental Stage-Specific Erythroid Enhancers(Figure 1A; Table S1). Upon differentiation of CD34+ HSPCs to
day 5 ProEs, 858 and 1,137 genes were significantly upregulated
(fold change > 1.5, FDR < 0.05) at fetal and adult stages, respec-
tively (Figure S1C). A total of 333 genes was upregulated at both
stages (Figure S1D). These genes are involved in heme biosyn-
thesis, iron homeostasis, and erythrocyte differentiation (Fig-
ure S1E), suggesting that a common set of gene signatures
required for erythroid functions is activated at both stages.
More importantly, comparative transcriptome profiling revealed
distinct gene expression programs at different stages of ery-
throid maturation. A total of 1,039 and 1,291 genes linked to
distinct functional annotations was differentially expressed in
fetal and adult day 5 (F5 and A5) ProEs, respectively (Figures
1C, S1F, and S1G). Of the differentially expressed genes,
93.7% had expression changes less than 4-fold, suggesting
that the majority of these genes differed to a modest extent
between fetal and adult stages (Figures 1C and 1D).
To investigate the basis of the distinct programs, we gener-
ated genome-wide maps for chromatin state and TF occupancy
by the ChIP-seq method. We profiled nine histone modifications
(H3K4me1/me2/me3, H3K9me3, H3K27me3, H3K36me2/me3,
H3K9ac, and H3K27ac) and six TFs (GATA1, TAL1, NFE2,
CTCF, RAD21, and RNA polymerase II) in fetal and adult ProEs.
GATA1, TAL1, and NFE2 are critical hematopoietic regulators
(Orkin and Zon, 2008). CTCF is required for transcriptional insu-
lation (Phillips and Corces, 2009). RAD21 is a component of the
cohesin complex and regulates chromatin architecture between
enhancers and promoters (Kagey et al., 2010). Most TFs were
expressed comparably between fetal and adult ProEs, except
that TAL1 and NFE2 were slightly upregulated in adult ProEs
(Figure S2A). We identified between 17,106 and 71,785 binding
peaks for histone marks, and between 5,664 and 22,835 peaks
for TFs (Table S2; Experimental Procedures). Of ChIP-seq
peaks, 95% (55 out of 58) and 97% (56 out of 58) were validated
by ChIP-qPCR in fetal and adult ProEs, respectively (Figures
S2B–S2H).
The genomic distributions of the profiled histone marks were
consistent with their known functions. H3K4me3, which is asso-
ciated with transcriptional initiation, was distributed primarily
near proximal promoters (Figure 1E). H3K4me1/me2, H3K9ac,
and H3K27ac, which are associated with open chromatin and
distal elements, showed diverse distributions across pro-
moters, intragenic, and intergenic regions. H3K36me3, which
is associated with transcriptional elongation, was found pri-
marily across gene bodies. Of note, the global distributions of
histone marks were highly similar at fetal and adult stages. The
distributions of profiled TFs were also comparable (Figure 1E;
Table S2).
Comparative Analysis of the b-Globin Gene Cluster
To explore the relationships between cis-regulatory elements,
chromatin signatures, and TF occupancy, we focused on the
b-globin gene cluster (Figure 2). The b-globin locus containsFigure 2. Chromatin State Maps and TF Occupancy within the Human
ChIP-seq density plots were generated from raw read data and loaded into the U
DHSs in fetal (green) and adult (red) ProEs are shown at the human b-globin gene c
globin genes (ε, Gg, Ag, d, and b). Dashed vertical line indicates the location of th
each globin gene. See also Figure S2.
Developmthe embryonic (ε), fetal (Gg, Ag), and adult (d, b) globin genes
that are expressed sequentially during development. The switch
from fetal (g) to adult (b) expression provides a paradigm for
tissue- and developmental stage-specific transcription (San-
karan et al., 2010). A locus control region (LCR) containing
erythroid-specific cis-regulatory elements is located upstream
and controls expression of the linked globin genes (Li et al.,
2002a).
The profiled histone marks and TFs showed spatial and
temporal density distributions that are qualitatively consistent
with their known functions within the b-globin gene cluster
(Figure 2). In fetal ProEs, the active fetal globin genes (Gg and
Ag) were associated strongly with activating histone marks
(H3K4me2/me3, H3K9ac, and H3K27ac). Conversely, these
marks were enriched only at the adult globin genes (d and b) in
adult ProEs, indicating that the fetal-to-adult globin switch is re-
flected in a switch of chromatin landscape within the cluster (Fig-
ure 2). The upstream LCR was enriched with active chromatin
marks in both fetal and adult ProEs. The peaks overlapped
with known DNase I-hypersensitive sites (DHSs) (Figure 2),
consistent with function of the LCR at both stages. In contrast
with a dynamic chromatin profile within the b-globin locus, the
occupancy of several TFs was largely comparable. GATA1 and
TAL1 predominantly occupied HS1–HS4 in both fetal and adult
ProEs. The profiles of several TFs were consistent with their
known functions within the locus. NFE2 predominantly occupied
the HS2 within the LCR and was associated with transcriptional
activation (Andrews et al., 1993). CTCF occupied the HS5 at both
stages, consistent with its insulator function within the LCR (Bell
et al., 2001; Li et al., 2002b).
Promoter Activities during Fetal and Adult
Erythropoiesis
To investigate the regulatory mechanisms for stage specificity,
we first characterized the chromatin features around RefSeq-
annotated promoters. We used H3K4me3 and H3K27me3 to
categorize promoters into four groups: active (marked by
H3K4me3 only); bivalent (marked by both H3K4me3 and
H3K27me3) (Bernstein et al., 2006; Boyer et al., 2006); repressed
(H3K27me3 only); and null (no H3K4me3/H3K27me3) (Figure 3A;
Table S3). The promoter activities highly correlated with mRNA
levels and were similar between fetal and adult ProEs (Figures
3A and 3B). Comparative analyses of the individual promoter
categories revealed significant overlaps between fetal and adult
cells (Figure 3C), indicating that the promoter activities are
largely invariant. Clustering analysis of all ChIP-seq densities at
proximal promoters indicated that the activating histone marks
(H3K4me1/me2/me3, H3K9ac, and H3K27ac) highly correlated
with each other and negatively correlated with repressive marks
(H3K9me3 and H3K27me3). Most profiled histone marks and
TFs displayed strong colocalization between fetal and adult
cells (Figure 3D), indicating that their binding to the proximal
promoters is largely invariant. Heatmap analysis revealed thatb-Globin Gene Cluster
CSC Genome Browser as custom tracks. Profiles for histone marks, TFs, and
luster. The human b-globin locus is depicted at the bottom containing five b-like
e upstream DHSs (1–5) within the LCR. Solid vertical line indicates the TSS of
ental Cell 23, 796–811, October 16, 2012 ª2012 Elsevier Inc. 799
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Figure 3. Promoter Activities in Fetal and Adult ProEs
(A) Promoters were categorized into active, bivalent, repressed, and null promoters. The fraction of each promoter category is shown for both fetal and adult
ProEs.
(B) mRNA expression values are shown for each promoter category in fetal and adult ProEs. Boxes showmedian line and quartiles. Whiskers show the boundary
(1.5 times of the interquartile range from the first or third quartile) to define outliers (red dots).
(C) Venn diagrams show genome-wide overlaps between fetal and adult ProEs for each promoter category.
(D) Unsupervised hierarchical clustering of all ChIP-seq data sets within the proximal promoter regions (2 to +1 kb of TSS) between fetal and adult ProEs.
Heatmap depicting the Pearson correlation coefficient of ChIP-seq read densities of indicated TFs and histone marks is shown.
(E) ChIP-seq density heatmaps are shown for the profiled histone marks and TFs within each promoter category.
See also Figure S3 and Table S3.
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Developmental Stage-Specific Erythroid Enhancersseveral profiled TFs, such as GATA1, NFE2, and CTCF, were
associated predominantly with active promoters at both stages
(Figure 3E).
To directly examine the correlation between chromatin sig-
natures, TF occupancy, and mRNA expression, we focused on
genes differentially expressed between fetal and adult ProEs.
Surprisingly, no obvious changes in chromatin signatures and800 Developmental Cell 23, 796–811, October 16, 2012 ª2012 ElsevTF occupancy were found within the promoters of differentially
expressed genes (Figure S3A), suggesting that the modest
expression changes (Figures 1C and 1D) are not accompanied
by changes in promoter activities. It is important to note that
the small subset of genes showing the strongest differences in
expression appears to be more likely than the rest to show
changes in H3K4me3 in its promoters (data not shown).ier Inc.
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Developmental Stage-Specific Erythroid EnhancersSimilarly, no significant changes in TF occupancy were found in
promoters that remained unchanged (‘‘invariant’’ promoters) or
changed their activities (‘‘variant’’ promoters) at fetal and adult
stages (Figures S3B and S3C). Thus, chromatin state and TF
occupancy at proximal promoters are largely invariant on aglobal
scale during fetal and adult erythropoiesis.
Identification of Developmental Stage-Specific
Enhancers
Studies of cells representing different lineages have indicated
that gene-distal enhancers are marked with highly cell-type-
specific histone modifications and strongly correlate to cell-
type-specific gene expression. We next investigated whether
enhancers also contribute to stage-specific gene expression
programs during fetal and adult erythropoiesis. To identify dis-
tal enhancers, we used histone marks H3K4me1, H3K9ac,
H3K27ac, and H3K27me3 to distinguish distal elements from
proximal promoters (Experimental Procedures). Genome-wide
analysis identified 8,947 and 11,709 active enhancers (that is,
marked by H3K4me1, H3K9ac or H3K27ac, DHSs, and absence
of H3K27me3) in fetal and adult ProEs, respectively. Enhancer
regions that overlapped the same chromatin marks in both cells
were identified as ‘‘common’’ enhancers (total 4,360) and the
remainder as ‘‘fetal-only’’ (total 2,594) or ‘‘adult-only’’ (total
5,730) enhancers (Figure 4A; Table S4). Representative common
and developmental stage-specific enhancers are shown (Figures
4B and S4D).
Heatmap analysis revealed that most of the profiled TFs asso-
ciated strongly with active enhancers at both stages (Figure 4C).
The binding intensities of the master regulators, such as GATA1
and TAL1, were higher at common enhancers as compared to
fetal- or adult-only enhancers (Figure 4C).We also detected pref-
erential association of activating histone marks (H3K4me1/2,
H3K9ac, and H3K27ac) and RNA Pol II with common enhancers
at both stages. To determine whether the chromatin signatures
for distal enhancers correlate with transcriptional activity, we
profiled enhancer peak densities around differentially expressed
genes (Figure 4D; Experimental Procedures). Remarkably, the
peak densities of fetal-only enhancers were significantly higher
at genes upregulated in fetal day 5 ProEs (F5-high genes) com-
pared to A5-high genes, and vice versa. Common enhancers
associated comparably with both F5- and A5-high genes (Fig-
ure 4D). Both common and stage-specific enhancers were
associated positively with mRNA levels in F5 and A5 ProEs (Fig-
ure S4A), and were highly enriched among genes activated
during erythropoiesis (Figure S4B). This analysis also indicated
that enhancer peaks were highly enriched in both intragenic
regions (TSS to TES) and gene-distal regions, indicating that
a significant subset of enhancers is located within gene bodies.
To functionally test whether the distal open chromatin marks
identified erythroid cell- and developmental stage-specific en-
hancers, we performed transient enhancer reporter assays in
erythroleukemia K562 cells and stable reporter assays in pri-
mary fetal or adult erythroid progenitor cells. Genomic fragments
containing putative enhancers markedly enhanced reporter
expression in K562 cells (Figure S4C). More importantly, fetal-
or adult-only enhancers displayed differential activities consis-
tent with their stage specificity (Figure 4E). Thus, distal regions
that show changes in open chromatin marks during fetal andDevelopmadult erythropoiesis are likely to be enriched for stage-specific
enhancers.
Enhancers often function through direct enhancer-promoter
contact by DNA loop formation. We next determined whether
the identified enhancers interact with proximal promoters by
chromosome conformation capture (Dekker et al., 2002). The
frequency of interaction between the IRF2 promoter and a
putative downstream enhancer was significantly higher than
other tested regions (Figure 4F). Importantly, the interaction
frequency increased 2-fold in adult relative to fetal ProEs,
consistent with adult-stage specificity. Conversely, a represen-
tative fetal-only enhancer within the COL4A5 gene displayed
increased interaction frequency in fetal ProEs. In contrast,
a representative common enhancer within the ZFPM1 gene
had comparable interaction frequency in both cells (Figures 4F
and S4D).
Enhancers Correlate with Differential Gene Expression
To directly assess whether stage-specific enhancers contribute
to differential gene expression patterns, we mapped enhancers
to target genes. We reasoned that selecting enhancers with
the most ‘‘biased’’ (for stage-specific enhancers) or ‘‘unbiased’’
(for common enhancers) activities would illustrate how distal
enhancers and the associated trans-acting regulators contribute
to the developmental stage-specific gene regulatory networks.
To this end, we first normalized the ChIP-seq data sets by
‘‘MAnorm’’ (Shao et al., 2012). In this approach, ChIP-seq data
sets from different samples were quantitatively compared after
rescaling of ChIP-seq signals by a set of common peaks (Exper-
imental Procedures). We then selected biased stage-specific
enhancers by a more stringent threshold requiring a fold
change R 2, which represents the ratio of enhancer binding
intensities between fetal and adult samples or vice versa. These
analyses identified 967 and 2,024 high-confidence (HC) fetal-
only and adult-only enhancers, respectively (Figures S5A and
S5B; Table S5). Similarly, we identified 2,970 HC common
enhancers (fold change < 2). Compared to enhancers from
previous overlap analysis (Figure 4A), the HC stage-specific
enhancers displayed more distinct stage-specific patterns for
histonemarks (Figures S5C and S5D), consistent with their stage
specificity. Finally, wemapped enhancers to target genes by two
approaches including ‘‘nearest neighbor gene’’ and ‘‘proximal
neighbor genes’’ (Figures S6A and S6B). By comparing the
gene expression patterns of enhancer targets, we observed no
significant difference between two approaches and choose the
‘‘nearest neighbor gene’’ approach for the remaining analyses
(Figure S6A; Table S7).
We then assessed the relationship between enhancer binding
and mRNA expression. Strikingly, genes targeted by HC fetal-
only enhancers were significantly enriched for F5-high genes
and depleted for A5-high genes (p = 4.8 3 1022). Genes tar-
geted by HC adult-only enhancers were significantly enriched
for A5-high genes (p = 1.9 3 1048). In contrast, genes targeted
by HC common enhancers were enriched for both F5- and
A5-high genes and had little predictive value (Figure 5A). These
analyses demonstrate that the stage-specific enhancers highly
correlate with changes in expression of the linked genes.
Notably, we found that the greater the expression level of a
gene increased in fetal or adult ProEs, the more likely it was toental Cell 23, 796–811, October 16, 2012 ª2012 Elsevier Inc. 801
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Figure 4. Identification of Developmental Stage-Specific Enhancers
(A) Active enhancers were identified as those genomic regions harboring H3K4me1, H3K9ac or H3K27ac, DHSs, and absence of H3K27me3. Venn diagram
shows the overlap between fetal and adult active enhancers.
(B) Representative fetal-only, adult-only, and common enhancers are shown. The putative active enhancers are depicted by shaded lines.
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Developmental Stage-Specific Erythroid Enhancersbe associated with fetal- or adult-stage-specific enhancers
(Figure 5B).
Active regulatory elements often contain low nucleosome
density and DHSs. We examined whether stage-specific en-
hancers correlate with DHSs at global scale using DNase-seq
(Neph et al., 2012). Strikingly, the enhancer activities highly
correlate to DNase-seq intensities in a stage-dependent manner
(Figure 5C). DNase-seq intensities were markedly increased in
the HC fetal-only enhancers as compared to the HC adult-only
enhancers in fetal erythroid cells, and vice versa. HC common
enhancers displayed comparable levels, suggesting that they
are largely invariant (Figure 5C).
We next explored whether enhancer maps might reveal
trans-regulatory factors involved in the stage-specific gene
expression. We first observed that the most enriched TF motifs
are recognized by erythroid master regulators (TAL::GATA1
and GATA1) in all three enhancer classes (Figure S6C), sug-
gesting that binding of these regulators does not distinguish
and/or predict stage selectivity. To identify TF motifs differen-
tially enriched between the stage-specific enhancers, we
enumerated instances of all known TF motifs and ranked
them according to their relative enrichment in fetal- or adult-
only enhancers. Among the motifs most enriched within the
HC fetal-only enhancers are recognition sites for known regula-
tors of hematopoiesis, including EVI1, GATA2, and GATA1 (Fig-
ure 5D). The list of motifs contained other known regulators
of cell-cycle regulation, proliferation, and apoptosis, such as
the SRF, MAF, and AP1 families. The most enriched motifs
within the HC adult-only enhancers are recognized by the
IRFs (IRF2, IRF1, and IRF8), CBF, EGR, and MYB proteins
(Figure 5D).
Candidate Regulators of Adult Enhancers
The motif enrichment analyses of developmental stage-specific
enhancers identified candidate regulators whose roles in human
erythropoiesis remain unexplored. We examined whether these
candidate regulators contribute to erythroid enhancer functions.
Expression of two of the nine IRF family genes, IRF2 and IRF6,
was specifically and progressively activated during adult eryth-
ropoiesis (Figure S7A). We confirmedmRNA and protein expres-
sion in CD34+ HSPCs and differentiating ProEs (Figures 5E and
S7B). Interestingly, studies in knockout mice have implicated
IRF2 in aspects of hematopoiesis (Matsuyama et al., 1993).
Besides defective lymphoid development, adult Irf2-deficient
mice are anemic due to ineffective erythropoiesis (Mizutani
et al., 2008). IRF2 can activate or repress gene transcription de-
pending on the cellular context (Harada et al., 1990; Lohoff et al.,
2000). IRF6 has been linked to Van der Woude and popliteal
pterygium syndromes, but its role in hematopoiesis has not(C) ChIP-seq density heatmaps are shown for the profiled histone marks and TF
H3K4me1, H3K9ac or H3K27ac, and H3K27me3) enhancers in both fetal (upper
(D) The distribution of fetal-only, adult-only, and common enhancers around F5-
(E) Predicted enhancers were active in reporter assays in primary erythroid cells
(F) 3C analysis within the representative fetal-only (COL4A5), adult-only (IRF2
anchoring point (black bar) and distal fragments (shaded bar) is shown. Results ar
DNase-seq (DHS) density plots are shown.
See also Figure S4 and Table S4.
Developmbeen explored (Kondo et al., 2002). The involvement of the
proto-oncogene MYB in regulation of erythropoiesis has been
established in mice containing null or hypomorphic Myb alleles
(Emambokus et al., 2003; Mucenski et al., 1991). Although the
mechanism remains elusive, MYB controls erythropoiesis by
coordinating cell-cycle regulation, differentiation, and globin
gene expression (Emambokus et al., 2003; Sankaran et al.,
2011). MYB expression was significantly higher in adult relative
to fetal ProEs (Figures 5E, S7A, and S7B).
To establish whether these factors also regulate human eryth-
ropoiesis, we used loss-of-function assays in primary erythroid
progenitors. Upon shRNA-mediated depletion of IRF2 or IRF6
expression, differentiating adult ProEs failed to activate a large
portion of A5-high signature genes, whereas F5-high signature
genes were slightly derepressed (Figures 5H, S7C, and S7D).
Similarly, depletion of MYB expression downregulated A5-high
genes. Moreover, loss of IRF2, IRF6, or MYB expression led to
downregulation of the signature genes induced during adult
erythropoiesis (A0-to-A5-high genes; Figure S7E), whereas the
F0-to-F5-high signature genes remained largely unaffected (Fig-
ure S7F). Gene set enrichment analysis (GSEA) was used with
A5-high signature genes. A marked decrease in expression of
A5-high signature genes was notable in the shRNA-treated cells
compared with controls, suggesting that these candidate regu-
lators are indispensable for activation of adult-high signature
genes (Figure 5I).
To directly assess the function of IRF2 in adult cells, we per-
formed ChIP-seq analysis of IRF2 in adult ProEs. IRF2 is prefer-
entially associated with adult-only enhancers, consistent with its
role in adult enhancer functions (Figures 5J and 5K). IRF2 occu-
pied 11.4% and 13.8% of HC adult-only and HC common
enhancers, respectively, whereas only 2.8% of HC fetal-only
enhancers were occupied (Figures 5L and 5M). Taken together,
these data demonstrate crucial roles of several candidate regu-
lators for the adult stage-specific program, and indicate that
trans-regulatory factors can be identified by an integrative
approach combining genomic profiling and motif enrichment
analysis.
Combinatorial Regulation of Stage-Specific Erythroid
Enhancers
Our comparative investigation of epigenetic state maps and TF
occupancy provided a unique system to explore the combinato-
rial regulation of erythroid enhancers. We performed k-means
clustering to classify each enhancer on the basis of TF occu-
pancy (Experimental Procedures). We observed four distinct
clusters (AE1–AE4) within adult enhancers characterized by
distinct patterns of TF occupancy (Figure 6A; Table S6). Notably,
AE1 was the largest cluster and occupied by the masters within active (fetal-only, adult-only, and common) and bivalent (marked by
panel) and adult (lower panel) ProEs.
high or A5-high genes, compared to all genes.
. Data are means ± SD of three independent experiments.
), and common (ZFPM1) enhancers. The interaction frequency between the
e means ± SD. ChIP-seq density plots for H3K4me1, H3K4me3, H3K27ac, and
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Figure 5. Enhancers Control Developmental Stage-Specific Gene Expression Programs
(A) Target genes of HC fetal-only, HC adult-only, and HC common enhancers were compared with genes differentially expressed between F5 and A5 ProEs. The
enrichment scores represent the fold change of the number of overlapped genes between enhancer target genes and differentially expressed genes compared to
the number expected at random using all genes as background. p values are calculated by Fisher’s exact test to quantify the significance of the relative bias
toward F5-high or A5-high genes using all differentially expressed genes as background.
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Developmental Stage-Specific Erythroid Enhancersregulators GATA1 and TAL1. AE2 was co-occupied by GATA1
and TAL1, together with the cohesin subunit RAD21. AE3 and
AE4 were predominantly associated with CTCF and NFE2,
respectively. To assess the temporal regulation of adult
enhancers, we next compared TF occupancy between fetal
and adult ProEs. Profiles of TF occupancy within the AE1 and
AE3 clusters were largely invariant at both stages. In contrast,
RAD21 and NFE2 profiles within the AE2 and AE4 clusters
were variable, increasing from little or no binding in fetal ProEs
to strong binding in adult ProEs (Figures 6A and S8A). These
analyses indicate that the variant enhancer clusters are associ-
ated with temporal changes in combinatorial regulatory patterns
and may contribute to stage-specific transcription.
To test this hypothesis, we mapped each enhancer to its
target gene and assessed the relationship between enhancer
clustering and mRNA expression. Genes targeted by AE2
(GATA1 + TAL1 + cohesin) and AE4 (NFE2) were significantly en-
riched for A5-high genes relative to F5-high genes (p = 3.6 3
106 and 1.3 3 107, respectively) (Figure 6B; Table S7), sug-
gesting that these variant enhancer clusters are strongly associ-
ated with adult-specific transcription. In contrast, the invariant
clusters (AE1 and AE3) showed less enrichment and had little
predictive value for stage selectivity (Figure 6B). To explore other
candidate regulators that may contribute to the temporal
changes in enhancer activity, we examined the enriched TF
motifs within the enhancer clusters. Consistent with the TF occu-
pancy patterns, motif analyses identified strong enrichment of
motifs for the corresponding TFs in each enhancer cluster (Fig-
ure 6C). Notably, the IRF2 motif was more enriched in variant
clusters (AE2 and AE4) than invariant clusters (Figure 6C),
consistent with increased IRF2 occupancy within the variant
clusters (Figures 6D and 6E), suggesting that it may contribute
to the temporal changes in enhancer activity by differential
enhancer association.
To gain further insight into the mechanistic role of IRF2 and
IRF6 in regulating adult enhancers, we identified their interacting
protein complexes by a proteomic screen in human erythroid
cells (Figure 7A). In addition to known interacting proteins such
as IRF2BP1, IRF2BP2, RELA, STAT1, and STAT2 (Childs and
Goodbourn, 2003; Rouyez et al., 2005), we identified subunits
of the mediator and cohesin complexes, implicating the associ-(B) Fractions of genes associated with HC fetal-only, HC adult-only, or HC comm
ProEs.
(C) Heatmap of DNase-seq intensities within the HC fetal-only, HC adult-only, or
(D) TF motifs associated with HC fetal-only or HC adult-only enhancers. Top ten m
shown. The ratios represent the fold change of the frequency to observe motif targ
are calculated by hypergeometric distribution to compare the motif presence be
(E) Expression of IRF2, IRF6, and MYB proteins in F5 and A5 ProEs.
(F and G) IRF2 and IRF6 proteins were depleted by lentiviral shRNAs in adult Pro
(H) Boxplots show mRNA expression changes of A5-high or F5-high genes upo
constructed as described in Figure 3B.
(I) Gene set enrichment analysis (GSEA) of A5-high signature genes using the expr
(J) ChIP-seq density plot is shown for IRF2 occupancy within the HC fetal-only and
of reads per kilobase pairs per million mapped reads) is shown for the 4 kb regio
(K) Venn diagrams show genome-wide overlaps between IRF2 peaks, fetal, and
(L) Fractions of IRF2-occupied HC fetal-only, HC adult-only, and HC common en
(M) Representative IRF2-occupied adult-only (AIG1 and ANKFY1) and common (T
GATA1, TAL1, IRF2, and DHS density plots are shown.
See also Figures S5, S6, and S7, and Tables S5 and S7.
Developmation between IRF2/IRF6 and the mediator and cohesin com-
plexes for function. Physical association between IRF2/IRF6
and the mediator subunits (MED1 and MED12) or the cohesin
subunits (RAD21 and SMC1A) was confirmed by independent
coIP experiments in K562 cells and primary erythroid cells
(Figures 7B and 7C). Of note, interaction between IRF2/IRF6
and the master regulators (GATA1 and TAL1), but not NFE2 or
CTCF, was also observed, indicating that they may function in
the same complexes. Importantly, IRF2 co-occupied a portion
of GATA1 and TAL1 peaks at a global scale (Figure 7D). The over-
lap was significantly higher within adult enhancers (Figure 7E). In
addition, both IRF2 and IRF6 genes were associated with adult-
only enhancers occupied by GATA1 and TAL1 in a stage-depen-
dent manner (Figure 7F). It remains unclear how IRF proteins
contribute to adult-stage selectivity of CTCF- or NFE2-enriched
enhancer cluster (AE3 and AE4; Figure 6A). We did not observe
interaction between IRF proteins, CTCF, and NFE2 (Figures 7A
and 7B). However, IRF proteins may act indirectly on NFE2
activity. For example, enforced expression of IRF2 in myeloid
progenitor cells induced megakaryocytic maturation and en-
hanced NFE2 binding activity to its consensus DNA sequences
(Stellacci et al., 2004).
To further explore how IRF2 cooperates with the erythroid
regulators within adult enhancers, we examined the TF
occupancy and chromatin state at a set of representative adult
enhancers (GATA1/IRF2 cobound or GATA1-only bound en-
hancers; Figure 7G) in adult ProEs in the presence or absence
of IRF2. Upon depletion of IRF2 expression, GATA1 occupancy
was diminished at seven out of eight GATA1/IRF2 cobound
enhancers, whereas it remained associated with GATA1-only
bound enhancers (Figure 7G). Binding of cohesin subunit
(RAD21) and mediator subunit (SMC1A) was abolished at
GATA1/IRF2 cobound enhancers, suggesting that IRF2 is indis-
pensable for maintaining the configuration of at least a subset of
adult stage-specific enhancers and contributes directly or indi-
rectly to the recruitment of master regulators. Taken together,
these data support a model in which the erythroid regulators
GATA1 and TAL1 trans-activate IRF2 and IRF6 by occupying
their distal enhancers during adult erythropoiesis. IRF2 and
IRF6 then cooperate with these regulators, as well as the medi-
ator and cohesin complexes, at a set of adult stage-specificon enhancers, conditional on changes in expression levels between F5 and A5
HC common enhancers in fetal and adult erythroid progenitors, respectively.
ost enriched motifs from mammalian TRANSFAC and JASPAR databases are
ets in HC adult-only enhancers compared to HC fetal-only enhancers. p values
tween HC adult-only and HC fetal-only enhancers.
Es, respectively.
n depletion of IRF2, IRF6, or MYB in adult ProEs, respectively. Boxplots are
ession array data of shIRF2, shIRF6, or shMYB relative to controls, respectively.
HC adult-only enhancers. The average read density in units of RPKM (number
n surrounding the enhancer summit.
adult enhancers.
hancers are shown, respectively.
CTN3) enhancers. ChIP-seq density plots for H3K4me1, H3K4me3, H3K27ac,
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Figure 6. Combinatorial Regulation of Enhancer Functions
(A) K-means clustering of all TF-associated adult enhancers (see Experimental Procedures). The heatmap on the left shows ChIP-seq read density of all TFs used
for clustering in adult ProEs. The heatmap on the right shows a side-by-side comparison of ChIP-seq read densities between fetal and adult ProEs within the
same enhancer clusters (AE1–AE4).
(B) Target genes of all adult enhancers and each enhancer cluster were compared with genes differentially expressed between F5 and A5 ProEs. The enrichment
scores and p values were calculated as in Figure 5A.
(C) Enrichment of selected JASPAR motifs in each enhancer cluster. The fold enrichment represents the frequency to observe motif targets in the selected
enhancer cluster compared to randomly selected regions from human genome.
(D) ChIP-seq density plot is shown for IRF2 within each enhancer cluster in adult ProEs.
(E) Fraction of IRF2-occupied enhancers within each enhancer cluster is shown.
See also Figure S8 and Tables S6 and S7.
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Developmental Stage-Specific Erythroid Enhancersenhancers and contribute to the differential activation of an adult
program (Figure 7H).
Transcriptional Networks of Erythroid Differentiation
To illustrate the temporal and stage-specific regulation of distal
enhancers, gene expression patterns, and TF occupancy during
fetal and adult erythropoiesis, we assembled the gene regulatory
networks by connecting enhancer activity and gene expression
changes (Enhancer-to-Gene) or TF occupancy and enhancer
activity (TF-to-Enhancer). In the Enhancer-to-Gene network,
we connected an edge from each enhancer to its corresponding
target gene and focused on those enhancers associated with
genes differentially expressed between fetal and adult ProEs
(Figure 8A; Table S8). The Enhancer-to-Gene connections
were largely exclusive and reflected stage specificity. Adult
stage-specific enhancers were predominantly associated with
genes upregulated in adult erythropoiesis. Conversely, fetal
stage-specific enhancers were highly associated with genes up-
regulated in fetal erythropoiesis. Common enhancers were806 Developmental Cell 23, 796–811, October 16, 2012 ª2012 Elsevassociated with both gene groups and had little predictive value
for gene expression changes.
To further delineate the relationship between TF occupancy
and enhancer activity, we generated the TF-to-Enhancer net-
work in which each edge was defined when at least one en-
richment peak for the profiled TFs was present within the
enhancer region (Figure 8B). Subsets of the common and
stage-specific enhancers were associated with TFs in a highly
stage-specific manner, suggesting that the temporal changes
in TF occupancy control differential enhancer activity. More-
over, the high degree of co-occupancy by multiple TFs within
each enhancer cluster suggests that they are coregulated by
several TFs. Of note, because a large portion of enhancers
were associated with yet to be determined TFs, the density
and complexity of the combinatorial regulation are likely even
greater than observed. Thus, our data suggest that gene-distal
enhancers are major determinants of developmental stage-
specific expression. The combinatorial assembly of master
regulators and transcriptional coregulators at developmentalier Inc.
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Figure 7. IRF Proteins Contribute to Adult Enhancer Activity
(A) IRF2 or IRF6-interacting proteins identified by proteomic screen in K562 stable cell lines. The number of peptides obtained from at least two independent
experiments is shown.
(B) Validation of protein interaction by coIP experiments in K562 stable cell lines. WB, western blot.
(C) Validation of protein interaction by coIP experiments in primary adult ProEs.
(D) Venn diagrams show genome-wide overlaps between IRF2, GATA1, and TAL1 ChIP-seq peaks.
(E) Venn diagrams show overlaps between IRF2, GATA1, and TAL1 ChIP-seq peaks within adult enhancers.
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Figure 8. Gene Regulatory Networks
Underlying Human Erythropoiesis
(A) Enhancer-to-Gene network. The edges repre-
sent the mapping of enhancers to their target
genes. The inner ring of the network represents
enhancers, colored according to whether they
were identified in fetal (green), adult (red), or both
(blue) samples. The outer ring represents differ-
entially expressed genes that are upregulated in
fetal (green) or adult (red) ProEs. Edges between
enhancers and genes are colored according to
their originating enhancers.
(B) TF-to-Enhancer network. The outer ring
represents the same set of enhancers as shown in
the inner ring of (A). The inner ring contains the
seven profiled TFs. Edges extending from these
TFs to an enhancer represent the presence of an
identified TF binding site in this enhancer region in
fetal (green), adult (red), or both (blue) samples.
Known protein-protein interactions (purple edges)
between the profiled TFs are also indicated.
See also Table S8.
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and temporal regulation of transcriptional networks during
human erythropoiesis.
DISCUSSION
Role of Enhancers in Developmental Stage-Specific
Transcription
Our comparative analyses of erythropoiesis at two develop-
mental stages have identified a set of developmental stage-
specific enhancers that are marked with highly stage-specific
histone marks and are functionally active in a stage-specific
manner. Compared to common enhancers, the stage-spe-
cific enhancers are more weakly associated with master regu-
lators (GATA1 and TAL1) as well as active histone marks
(Figure 4C). These data suggest that stage-specific enhancers
may function to modulate expression of target genes (‘‘fine-
tuning’’) rather than to control genes ‘‘on’’ or ‘‘off.’’ Consistent
with this hypothesis, the vast majority of the differentially ex-
pressed genes display only modest changes in expression
between fetal and adult stages (Figures 1C and 1D). Alterna-
tively, the stage-specific enhancers may be bound/activated
in only a proportion of the cells, whereas the common en-
hancers are bound/activated in all cells. Single-cell analysis is
needed to determine the frequency of expression of stage-
specific genes and enhancer activities. Nevertheless, our find-
ings suggest that distal enhancers are the major determinants
of developmental stage-specific gene expression programs.
Further characterization of these stage-specific enhancers pro-
vides a path to discovery of candidate regulators that contribute
to the differential enhancer activity required for erythroid
development.(F) ChIP-seq density plots for H3K4me1, H3K4me3, H3K27ac, GATA1, and TAL1,
adult (red) ProEs, respectively. Putative adult-specific enhancers are indicated b
(G) ChIP-qPCR analysis of representative GATA1/IRF2 cobound enhancers and G
transduced adult ProEs. Results are means ± SD of three independent experime
(H) Model of the temporal regulation of adult-high genes through gene-distal enh
808 Developmental Cell 23, 796–811, October 16, 2012 ª2012 ElsevRole of Master Regulators in Stage-Specific Gene
Expression
Lineage-specifying master regulators are required for program-
ming of global gene expression toward specific lineages and
often exhibit dual functions by promoting their own lineage
decisions while antagonizing factors favoring other choices.
Genome-wide studies inmultiple cell types have revealed pivotal
roles of master regulators in establishing gene expression pro-
grams by diverse mechanisms including cooperation with other
cofactors and chromatin-modifying complexes (Cheng et al.,
2009; Fujiwara et al., 2009; Kassouf et al., 2010; Pilon et al.,
2011; Tijssen et al., 2011; Yu et al., 2009). Moreover, studies
utilizing embryonic stem (ES) cells and multiple hematopoietic
cell types have shown that master regulators of various cell line-
ages direct signaling transcription factors to cell-type-specific
gene programs during differentiation and regeneration (Chen
et al., 2008; Mullen et al., 2011; Trompouki et al., 2011). Here
we demonstrate that master regulators act cooperatively within
active enhancers but have little predictive value for stage-
specific transcription. Instead, a set of stage-specific cofactors
and signaling pathways, such as IRF2 and IRF6, collaborate
with master regulators and confer stage specificity. Thus, we
provide a model in which master regulators are actively involved
in cell-type and developmental stage-specific transcriptional
programs, but their specific roles are instructed and refined by
developmental stage-specific cofactors to establish stage
specificity.
Potential Implications in Hematologic Malignancies and
‘‘Reprogramming’’ Hematopoietic Differentiation
Mutation or altered regulation of master TFs has been linked to
hematologic malignancies. Our findings suggest thatand DHS density plots are shown for both IRF2 and IRF6 loci in fetal (green) and
y shaded vertical lines.
ATA1-only bound enhancers in control and IRF2 lentiviral shRNA (sh1 and sh2)
nts.
ancers.
ier Inc.
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Developmental Stage-Specific Erythroid Enhancerstranscriptional coregulators or signaling pathways may be
essential for the proper functionality of master regulators and,
thus, may be potential targets for therapeutic interventions.
Particularly, cell-type and stage-specific activitymay offer a ther-
apeutic option that is more selective and effective. The stage-
specific activity of coregulators may provide an opportunity to
‘‘reprogram’’ hematopoietic differentiation by switching of gene
expression programs. For example, LIN28B gene is specifically
expressed in fetal cells and harbors a fetal stage-specific
enhancer (Table S1; Figures 4E and S4C). Ectopic expression
of LIN28B reprograms adult hematopoietic progenitors to fetal-
like lymphocytes in a cell-autonomous manner (Yuan et al.,
2012), suggesting that LIN28B plays a critical role in regulating
fetal identity. Our studies indicate that the developmental
stage-specific enhancers may contribute to the differential
expression of LIN28B gene, and interference with enhancer
functionality may lead to altered gene expression. Manipulation
of stage-selective cis- or trans-regulatory elements can highlight
therapeutic interventions in hematologic disorders, such as
sickle cell anemia and b-thalassemias, in which the fetal-to-adult
hemoglobin switch is important for pathogenesis, and its
reversal can ameliorate disease severity (Xu et al., 2011). Thus,
comparative analyses of enhancer signatures provide critical
insights into global networks regulating transcription during the
ontogeny and pathogenesis of human hematopoiesis.
EXPERIMENTAL PROCEDURES
Cells and Cell Culture
Primary human fetal CD34+ HSPCs were isolated from second-trimester fetal
livers as described (Van Handel et al., 2010). Primary human adult CD34+
HSPCs were obtained from Yale Center of Excellence in Molecular Hema-
tology. Primary fetal or adult erythroblasts were generated ex vivo as
described (Sankaran et al., 2008; Xu et al., 2010). The K562-BirA, K562-
FLAG-Bio-IRF2 (FB-IRF2), and K562-FLAG-Bio-IRF6 (FB-IRF6) stable cell
lines were generated as described (Kim et al., 2009).
ChIP
ChIP was performed as described (Xu et al., 2010). See also Supplemental
Experimental Procedures.
ChIP-Seq Analysis
For ChIP-seq analysis using the HeliScope Single Molecule Sequencer, ChIP
DNA was processed for 30 polyA tailing, followed by 30 ddATP blocking as
described (Hart et al., 2010). Processing samples by ligation, amplification,
and size selection are not required by Helicos sequencing. Peaks were called
using Model-based Analysis for ChIP-Seq (MACS) (Zhang et al., 2008). See
also Supplemental Experimental Procedures.
Gene Expression Analysis
mRNA profiling of primary fetal and adult HSPCs (CD34+; F0 and A0) and
maturing erythroid cells (ProE; F3, F5, F7, A3, A5, and A7) was performed using
Affymetrix human genome U133 Plus 2.0 arrays. See also Supplemental
Experimental Procedures.
Chromatin Conformation Capture
Chromatin conformation capture (3C) assay was performed as described
(Dekker et al., 2002; Xu et al., 2010). See also Supplemental Experimental
Procedures.
Lentiviral RNAi and Enhancer Reporter Assay
Lentiviral RNAi was performed as described (Xu et al., 2010). For enhancer
reporter assay in primary human erythroid progenitors, genomic fragmentsDevelopmwere cloned into a lentiviral vector in front of a TK minimal promoter driving
GFP expression. See also Supplemental Experimental Procedures.
Multiprotein Complex Purification and Proteomic Analysis
IRF2- and IRF6-containing multiprotein complexes were purified as described
(Kim et al., 2009). See also Supplemental Experimental Procedures.
ACCESSION NUMBERS
The cDNA microarray and ChIP-seq data were deposited in the Gene Expres-
sion Omnibus (http://www.ncbi.nlm.nih.gov/geo) under accession number
GSE36994.
SUPPLEMENTAL INFORMATION
Supplemental Information includes eight figures, eight tables, and Supple-
mental Experimental Procedures and can be found with this article online at
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